S Huang, Y Zhao, W Lai, J Tan, X Zheng… - Cancer Biology & …, 2023 - Taylor & Francis
With the success of immune checkpoint inhibitors (ICI), such as anti-programmed death-1
(PD-1) antibody for solid tumors and lymphoma immunotherapy, a number of clinical trials …